These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25790049)

  • 1. Production, characterization and immunogenicity of P particles derived from norovirus GII.4 genotype 2004 variant.
    Su W; Gao J; Zang Y; Wu H; Wang L; Hu H; Yu X; Kong W; Jiang C
    Acta Virol; 2015 Mar; 59(1):33-9. PubMed ID: 25790049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.
    Chen W; Kang T; Yuan R; Shao C; Jing S
    Biotechnol Lett; 2020 Jul; 42(7):1211-1218. PubMed ID: 32088791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.
    Tamminen K; Huhti L; Koho T; Lappalainen S; Hytönen VP; Vesikari T; Blazevic V
    Immunology; 2012 Jan; 135(1):89-99. PubMed ID: 22044070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
    Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
    J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses against norovirus GII.4 virus-like particles in mice.
    Ushijima H; Machida S; Nomura A; Khamrin P; Tran DN; Nomura H; Hayakawa S
    Acta Virol; 2016; 60(4):339-346. PubMed ID: 27928912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
    Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
    Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30678195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norovirus GII.4 strain antigenic variation.
    Lindesmith LC; Donaldson EF; Baric RS
    J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norovirus GII.4 antibodies in breast milk and serum samples: their role preventing virus-like particles binding to their receptors.
    Khodayar-Pardo P; Martínez-Costa C; Carmona-Vicente N; Buesa J
    Pediatr Infect Dis J; 2014 Jun; 33(6):554-9. PubMed ID: 24830517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogenetic and biological characterizations of a GI.3 norovirus.
    Zheng L; Zhang H; Ma J; Liu J; Ma S; Wang M; Huo Y
    Infect Genet Evol; 2020 Nov; 85():104554. PubMed ID: 32927119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viral Immunol; 2016 Jun; 29(5):315-9. PubMed ID: 27135874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
    Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
    J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
    Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
    J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.